Literature DB >> 15653646

Radiobiologic principles in radionuclide therapy.

Amin I Kassis1, S James Adelstein.   

Abstract

Although the general radiobiologic principles underlying external beam therapy and radionuclide therapy are the same, there are significant differences in the radiobiologic effects observed in mammalian cells. External beam and brachytherapy emissions are composed of photons, whereas radiations of interest in radionuclide therapy are particulate. The special features that characterize the biologic effects consequent to the traversal of charged particles through mammalian cells are explored with respect to DNA lesions and cellular responses. Information about the ways in which these radionuclides are used to treat cancers in experimental models are highlighted.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15653646

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  49 in total

1.  Nuclisome--targeting the tumor cell nucleus.

Authors:  Lars Gedda; Katarina Edwards
Journal:  Tumour Biol       Date:  2012-06

2.  Evaluation of new iodinated acridine derivatives for targeted radionuclide therapy of melanoma using 125I, an Auger electron emitter.

Authors:  Maryline Gardette; Janine Papon; Mathilde Bonnet; Nicolas Desbois; Pierre Labarre; Ting-Dee Wu; Elisabeth Miot-Noirault; Jean-Claude Madelmont; Jean-Luc Guerquin-Kern; Jean-Michel Chezal; Nicole Moins
Journal:  Invest New Drugs       Date:  2010-06-22       Impact factor: 3.850

Review 3.  Continuing pursuit for ideal systemic anticancer radiotherapeutics.

Authors:  Marlein Miranda Cona; Huaijun Wang; Junjie Li; Yuanbo Feng; Feng Chen; Peter de Witte; Alfons Verbruggen; Yicheng Ni
Journal:  Invest New Drugs       Date:  2011-10-18       Impact factor: 3.850

4.  Tumor-targeted HPMA copolymer-(RGDfK)-(CHX-A''-DTPA) conjugates show increased kidney accumulation.

Authors:  Mark P Borgman; Tomika Coleman; Rohit B Kolhatkar; Sandra Geyser-Stoops; Bruce R Line; Hamidreza Ghandehari
Journal:  J Control Release       Date:  2008-07-18       Impact factor: 9.776

5.  Calculation of electron dose to target cells in a complex environment by Monte Carlo code "CELLDOSE".

Authors:  Elif Hindié; Christophe Champion; Paolo Zanotti-Fregonara; Domenico Rubello; Nicole Colas-Linhart; Laura Ravasi; Jean-Luc Moretti
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-08-09       Impact factor: 9.236

6.  Actinium-225 for Targeted α Therapy: Coordination Chemistry and Current Chelation Approaches.

Authors:  Nikki A Thiele; Justin J Wilson
Journal:  Cancer Biother Radiopharm       Date:  2018-06-11       Impact factor: 3.099

Review 7.  The biology of the sodium iodide symporter and its potential for targeted gene delivery.

Authors:  Mohan Hingorani; Christine Spitzweg; Georges Vassaux; Kate Newbold; Alan Melcher; Hardev Pandha; Richard Vile; Kevin Harrington
Journal:  Curr Cancer Drug Targets       Date:  2010-03       Impact factor: 3.428

8.  Time for radiobiology in the nuclear medicine community.

Authors:  Marco Chianelli; Alberto Signore; Luigi Mansi; Massimo Salvatori
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-07       Impact factor: 9.236

Review 9.  (223)Ra and other bone-targeting radiopharmaceuticals-the translation of radiation biology into clinical practice.

Authors:  P G Turner; J M O'Sullivan
Journal:  Br J Radiol       Date:  2015-03-26       Impact factor: 3.039

Review 10.  Auger radiation targeted into DNA: a therapy perspective.

Authors:  Franz Buchegger; Florence Perillo-Adamer; Yves M Dupertuis; Angelika Bischof Delaloye
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-08-08       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.